Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
The Journal of Laboratory and Clinical Medicine
|
February 1, 1984
Protease inhibition of natural killer (NK) and antibody-dependent cell-mediated cytoxicity (ADCC) activities
R A Floyd, C Y Kuo, T J Yoo, et al.
The Journal of Cell Biology
|
February 1, 1988
Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta
A E Postlethwaite, R Raghow, G P Stricklin, et al.
Arthritis and Rheumatism
|
January 1, 1990
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis
J J Cush, P E Lipsky, A E Postlethwaite, et al.
Arthritis and Rheumatism
|
May 19, 2000
Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen
K M McKown, L D Carbone, J Bustillo, et al.
The American Journal of Physiology
|
September 1, 1992
Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments
L Kapás, L Hong, A B Cady, et al.
The Journal of Biological Chemistry
|
March 5, 1988
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells
J Keski-Oja, R Raghow, M Sawdey, et al.
Clinical and Experimental Immunology
|
November 15, 2006
Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles
L D Carbone, K J Warrington, K D Barrow, et al.
The American Journal of Physiology
|
September 11, 1990
Interleukin 1 alpha and an interleukin 1 beta fragment are somnogenic
F Obal, M Opp, A B Cady, et al.
Clinical and Experimental Immunology
|
June 10, 2010
Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma)
S P Atamas, I G Luzina, J Ingels, et al.
Arthritis and Rheumatism
|
January 6, 2001
The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis
L K Myers, A H Kang, A E Postlethwaite, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
The Journal of Laboratory and Clinical Medicine
|
February 1, 1984
Protease inhibition of natural killer (NK) and antibody-dependent cell-mediated cytoxicity (ADCC) activities
R A Floyd, C Y Kuo, T J Yoo, et al.
The Journal of Cell Biology
|
February 1, 1988
Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta
A E Postlethwaite, R Raghow, G P Stricklin, et al.
Arthritis and Rheumatism
|
January 1, 1990
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis
J J Cush, P E Lipsky, A E Postlethwaite, et al.
Arthritis and Rheumatism
|
May 19, 2000
Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen
K M McKown, L D Carbone, J Bustillo, et al.
The American Journal of Physiology
|
September 1, 1992
Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments
L Kapás, L Hong, A B Cady, et al.
The Journal of Biological Chemistry
|
March 5, 1988
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells
J Keski-Oja, R Raghow, M Sawdey, et al.
Clinical and Experimental Immunology
|
November 15, 2006
Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles
L D Carbone, K J Warrington, K D Barrow, et al.
The American Journal of Physiology
|
September 11, 1990
Interleukin 1 alpha and an interleukin 1 beta fragment are somnogenic
F Obal, M Opp, A B Cady, et al.
Clinical and Experimental Immunology
|
June 10, 2010
Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma)
S P Atamas, I G Luzina, J Ingels, et al.
Arthritis and Rheumatism
|
January 6, 2001
The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis
L K Myers, A H Kang, A E Postlethwaite, et al.
Page
of 9